Click to copy, then share by pasting into your messages, comments, social media posts and websites.
Click to copy, then add into your webpages so users can view and engage with this video from your site.
Report Content
We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.
Thank you for submitting your report
We will investigate and take the appropriate action.
Must see - Was the COVID-19 PCR Test Meant to Detect a Virus - Kary Mullis - inventor of PCR testing
This is a must see interview with the inventor of The PCR testing, which is now being used to falsely diagnose and treat people with COVID. ! As the CDC says itself in the how to use manual, this test can not prove that one is infected with the virus, nor prove that these RNA segments are the cause of the disease!
https://www.fda.gov/media/134922/download
"Performance of the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel has only been established in upper and lower respiratory specimens (such as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).
•Negative results do not preclude 2019-nCoV infection and should not be used as the sole basis for treatment or other patient management decisions. Optimum specimen types and timing for peak viral levels during infections caused by 2019-nCoV have not been determined. Collection of multiple specimens (types and time points) from the same patient may be necessary to detect the virus.
•A false-negative result may occur if a specimen is improperly collected, transported or handled. False-negative results may also occur if amplification inhibitors are present in the specimen or if inadequate numbers of organisms are present in the specimen.
•Positive and negative predictive values are highly dependent on prevalence. False-negative test results are more likely when prevalence of disease is high. False-positive test results are more likely when prevalence is moderate to low.
•Do not use any reagent past the expiration date.
•If the virus mutates in the rRT-PCR target region, 2019-nCoV may not be detected or may be detected less predictably. Inhibitors or other types of interference may produce a false-negative result. An interference study evaluating the effect of common cold medications was not performed.
•Test performance can be affected because the epidemiology and clinical spectrum of infection caused by 2019-nCoV is not fully known. For example, clinicians and laboratories may not know
he optimum types of specimens to collect, and, during the course of infection, when these specimens are most likely to contain levels of viral RNA that can be readily detected.
Detection of viral RNA may not indicate the presence of infectious virus or that 2019-nCoV is the causative agent for clinical symptoms.
•The performance of this test has not been established for monitoring treatment of 2019-nCoV infection.
•The performance of this test has not been established for screening of blood or blood products for the presence of 2019-nCoV.
•This test cannot rule out diseases caused by other bacterial or viral pathogens"
https://www.fda.gov/media/134922/download
For another awesome interview with Mullins look here
http://aidswiki.net/index.php?title=Document:Farber_interviews_Mullis
Category | Health & Medical |
Sensitivity | Normal - Content that is suitable for ages 16 and over |
Playing Next
Warning - This video exceeds your sensitivity preference!
To dismiss this warning and continue to watch the video please click on the button below.
Note - Autoplay has been disabled for this video.